Role of Alcohol in Prevention of Recurrence of the Accidentally Opened Angular Dermoid Cyst

February 21, 2025 updated by: Mohamed Yasser Sayed Saif, Beni-Suef University
Purpose to evaluate the effect of alcohol used in accidentally opened dermoid cyst in prevention of inflammation and recurrence Patient and method: Itt is a comparative interventional study ,performed on 60 patients with external angular dermoid cysts that were accidentally opened during surgical removal , they were divided into two groups ,Group (A) includes 30 patients where only saline was used to wash the surgical field while group(B) includes 30 patients where ethyl alcohol 70% was used.

Study Overview

Detailed Description

  1. Study Design and Rationale:

    This is a comparative interventional study designed to evaluate the efficacy of 70% ethyl alcohol in preventing inflammation and recurrence in cases of accidentally opened external angular dermoid cysts during surgical removal. The rationale for using 70% ethyl alcohol is based on its antimicrobial and antiseptic properties, which may reduce the risk of postoperative infection and cyst recurrence compared to saline irrigation alone.

  2. Patient Recruitment and Group Allocation:

    Recruitment Sites: Patients were recruited from outpatient clinics at Beni-Suef University Hospitals, Fayoum University Hospitals, and MUST University Hospital.

    Recruitment Period: May 2022 to May 2024.

    Group Allocation:

    Group A (Control Group): 30 patients treated with saline irrigation.

    Group B (Intervention Group): 30 patients treated with 70% ethyl alcohol.

  3. Surgical Procedure:

    Preoperative Preparation:

    Patients were positioned supine, and the surgical site was sterilized using standard antiseptic protocols.

    Local or general anesthesia was administered based on patient and surgeon preference.

    Incision and Dissection:

    A skin incision was made below the eyebrow, followed by subcutaneous and orbicularis dissection to expose the dermoid cyst.

    Care was taken to avoid accidental rupture, but if the cyst was opened, the following steps were implemented.

    Cyst Management:

    The cyst walls and contents were meticulously removed from the surgical field to minimize residual material.

    Group A (Saline Group): The surgical field was irrigated with sterile saline solution to remove any remnants.

    Group B (Alcohol Group): The surgical field was cleaned using a gauze soaked with 70% ethyl alcohol to ensure thorough disinfection.

    Wound Closure:

    The wound was closed in layers using absorbable sutures for subcutaneous tissues and non-absorbable sutures or skin adhesive for the skin.

    A sterile dressing was applied.

  4. Postoperative Care:

    Medications:

    Both groups received the same regimen of systemic antibiotics (e.g., amoxicillin-clavulanate) and anti-inflammatory drugs (e.g., ibuprofen) for 5-7 days to prevent infection and inflammation.

    Follow-Up:

    Patients were monitored at 1 week, 1 month, 3 months, and 6 months postoperatively.

    At each visit, the surgical site was assessed for signs of inflammation, infection, or recurrence.

    Any adverse events or complications were recorded.

  5. Data Collection and Analysis:

    Data Collected:

    Demographic data (age, sex).

    Intraoperative details (cyst size, extent of spillage).

    Postoperative outcomes (infection, inflammation, recurrence).

    Statistical Methods:

    Data were analyzed using SPSS version 24.

    Quantitative variables (e.g., cyst size) were summarized as mean ± standard deviation.

    Categorical variables (e.g., recurrence rates) were summarized as frequencies and percentages.

    Comparisons between groups were performed using:

    ANOVA with post hoc tests for continuous variables.

    Chi-square test or Fisher's exact test for categorical variables.

    Pearson correlation coefficient was used to assess relationships between quantitative variables.

    A p-value < 0.05 was considered statistically significant.

  6. Technical Considerations:

    Ethyl Alcohol Concentration: 70% ethyl alcohol was chosen for its optimal balance between antimicrobial efficacy and tissue safety.

    Saline Irrigation: Sterile saline was used as a control to mimic standard surgical practice.

    Standardization: All procedures were performed by experienced surgeons to ensure consistency in technique and cyst management.

  7. Ethical and Regulatory Compliance:

    Informed Consent: Written informed consent was obtained from all participants prior to surgery.

    Ethical Approval: The study protocol was approved by the Ethics Committee of Beni-Suef University and adhered to the principles of the Helsinki Declaration.

    Patient Safety: Adverse events were monitored and managed promptly to ensure patient safety.

  8. Limitations:

    The study is limited by its sample size (n=60), which may affect the generalizability of the results.

    The follow-up period of 6 months may not be sufficient to capture long-term recurrence rates.

    Potential variability in surgical technique among different surgeons.

  9. Expected Outcomes:

The study aims to demonstrate that 70% ethyl alcohol is more effective than saline in reducing postoperative inflammation and recurrence in accidentally opened dermoid cysts.

If proven effective, this intervention could be incorporated into standard surgical protocols for dermoid cyst management.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Banī Suwayf, Egypt
        • Beni Suef University
      • Fayoum, Egypt
        • Fayoum university Hospital
      • Giza, Egypt
        • Misr University for Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Clinical diagnosis of external angular dermoid cyst.

Accidental opening of the dermoid cyst during surgical removal.

Age: Patients of any age eligible for surgical intervention.

Willingness to provide written informed consent for participation in the study.

Exclusion Criteria:

Recurrent dermoid cysts (previously treated or excised).

Complicated dermoid cysts (e.g., preoperatively ruptured or infected).

Patients with contraindications to the use of ethyl alcohol (e.g., known hypersensitivity or allergy).

Patients with systemic conditions that may impair wound healing (e.g., uncontrolled diabetes, immunocompromised states).

Patients who are pregnant or breastfeeding.

Patients unable or unwilling to comply with follow-up visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group (A)
only saline was used to wash the surgical field

Skin incision was done below the eyebrow, subcutaneous and orbicularis dissection was done to remove the cysts. Upon accidental opening of the cyst then removal of the cyst walls and its contents from the surgical field as much as possible was done.

At this step, in group (A) only saline was used to wash the surgical field from any remnants. In group (B) the surgical field was cleaned with a gauze soaked with ethyl alcohol 70%. Then closure of the wound in both groups.

Active Comparator: group (B)
ethyl alcohol 70% was used to wash the surgical field

Skin incision was done below the eyebrow, subcutaneous and orbicularis dissection was done to remove the cysts. Upon accidental opening of the cyst then removal of the cyst walls and its contents from the surgical field as much as possible was done.

At this step, in group (A) only saline was used to wash the surgical field from any remnants. In group (B) the surgical field was cleaned with a gauze soaked with ethyl alcohol 70%. Then closure of the wound in both groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post-operative inflammation
Time Frame: 6 month

The primary outcome of post-operative inflammation measures the incidence of clinically significant inflammatory responses at the surgical site following excision of an accidentally opened external angular dermoid cyst. Inflammation is defined as the presence of two or more of the following clinical signs:

Erythema (redness) extending ≥1 cm from the wound edges.

Edema (swelling) at or around the surgical site.

Local warmth compared to adjacent skin.

Pain or tenderness reported by the patient or elicited during palpation.

Purulent discharge from the incision site.

6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recurrence
Time Frame: 6 month
The recurrence outcome measures the number of participants who experience a reappearance of the external angular dermoid cyst at the surgical site within the 6-month follow-up period after surgical removal. Recurrence is defined as the presence of a palpable mass or radiologically confirmed lesion (via ultrasound or MRI) that exhibits characteristics consistent with a dermoid cyst. This outcome is a critical measure of the long-term efficacy of the surgical intervention and the intraoperative cleaning method (saline vs. 70% ethyl alcohol) in preventing residual cyst material from causing regrowth.
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

May 30, 2024

Study Registration Dates

First Submitted

April 28, 2024

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 21, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe